NSRGF Stock Recent News

Nestle shares slumped Friday after the food giant abruptly announced the departure of its chief executive.

Britain's competition watchdog has decided not to pursue its probe into the infant formula and follow-on milk market, despite identifying a range of concerns. According to the Competition and Markets Authority, the combination of regulation, manufacturer behaviour, and customer needs has led to poor market outcomes.

Upon closing, Seres to receive $175M cash infusion, including an upfront payment, prepayment of a future commercial milestone payment, and an equity investment in Seres common stock, less approximately $20M in settlement of net obligations between the Parties; anticipated deal closing in the next 90 days

Swiss consumer brands behemoth Nestlé S.A. sparked a share sell off on Thursday after slashing its full-year sales guidance.

Transaction ensures Nestlé Health Science will continue to commercialize the product BRIDGEWATER, N.J. , June 6, 2024 /PRNewswire/ -- Seres Therapeutics, Inc. (Nasdaq: MCRB), announced today that it has agreed to a non-binding memorandum of understanding with Nestlé Health Science in which Nestlé Health Science will acquire certain tangible and intangible assets associated with VOWST (fecal microbiota spores, live-brpk) capsules.

Nestlé is launching a line of food products tailored to people using weight-loss medication in an effort to capitalize on a market expected to reach $30 billion in the next six years.

Nestlé is launching a frozen food brand specifically aimed at people taking GLP-1 diabetes and weight loss drugs like Ozempic and Wegovy, the company announced Tuesday, part of the food giant's wider strategy to offset potential sales losses as appetite-suppressing drugs grow popular.

The firm said it expects organic sales growth of around 4% in 2024, and a "moderate increase" in its underlying trading operating profit margin.

Britain's Competition and Markets Authority (CMA) has opened a new phase of its investigation into the market for baby formula in the UK. Having found that the price of baby formula had climbed by 25% over the past two years last November, the CMA said a market study would now begin, allowing the regulator to use its compulsory information-gathering powers.

Love is in the air – at least, for certain picks on the stock market it is. America's National Retail Federation says that nearly $26 billion will be spent on Valentines Day this year in the U.S. alone, representing “a new high of $14.